Atosiban-BFS

1.Composition

Atosiban 7.5 mg/ml

2.Dosage Form

Solution for injection

3.Indication

Atosiban is indicated to delay imminent pre-term birth in pregnant women with:− regular uterine contractions of at least 30 seconds duration at a rate of ≥ 4 per 30 minutes− a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of ≥ 50%− a gestational age from 24 until 33 completed weeks− a normal foetal heart rate